Search research articles
Contact Us
Filters
Showing results (261-270 of 350) with videos related to
Page
of 35
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
September 26, 2025
Evaluation and Mitigation of Time-Dependent Confounding Effects in Conventional Exposure-Response Analyses for Oncology Drugs
Xuefen Yin, Ye Xiong, Youwei Bi, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 22, 2021
Application of a dual mechanistic approach to support bilastine dose selection for older adults
Chaejin Kim, Valentina Lo Re, Monica Rodriguez, et al.
British Journal of Clinical Pharmacology
|
February 11, 2011
Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects
Marieke Liem-Moolenaar, Peter de Boer, Maarten Timmers, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
February 5, 2010
Effects of mild hypothermia on hemodynamics in cardiac arrest survivors and isolated failing human myocardium
Claudius Jacobshagen, Theresa Pelster, Anja Pax, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 8, 2021
Development of a model-based clinical trial simulation platform to optimize the design of clinical trials for Duchenne muscular dystrophy
Karthik Lingineni, Varun Aggarwal, Juan Francisco Morales, et al.
Antimicrobial Agents and Chemotherapy
|
June 6, 2018
Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model
G L Drusano, Jenny Myrick, Michael Maynard, et al.
Antimicrobial Agents and Chemotherapy
|
September 26, 2018
Activity of Moxifloxacin against <i>Mycobacterium tuberculosis</i> in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model
Arnold Louie, Brandon Duncanson, Jenny Myrick, et al.
Pharmaceutics
|
February 25, 2023
Leveraging Physiologically Based Modelling to Provide Insights on the Absorption of Paliperidone Extended-Release Formulation under Fed and Fasting Conditions
Saima Subhani, Viera Lukacova, Chaejin Kim, et al.
Cardiovascular Diabetology
|
December 24, 2025
Glucagon-like peptide-1 receptor agonists and risk for cardiovascular events in older adults treated with levothyroxine: a target trial emulation
Fanxing Du, Naykky M Singh Ospina, Yishan Chen, et al.
Antimicrobial Agents and Chemotherapy
|
September 9, 2020
Building Optimal Three-Drug Combination Chemotherapy Regimens
G L Drusano, Michael N Neely, Sarah Kim, et al.
Page
of 35
Search research articles
Search
Showing results (261-270 of 350) with videos related to
Sort By:
Page
of 35
CPT: Pharmacometrics & Systems Pharmacology
|
September 26, 2025
Evaluation and Mitigation of Time-Dependent Confounding Effects in Conventional Exposure-Response Analyses for Oncology Drugs
Xuefen Yin, Ye Xiong, Youwei Bi, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 22, 2021
Application of a dual mechanistic approach to support bilastine dose selection for older adults
Chaejin Kim, Valentina Lo Re, Monica Rodriguez, et al.
British Journal of Clinical Pharmacology
|
February 11, 2011
Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects
Marieke Liem-Moolenaar, Peter de Boer, Maarten Timmers, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
February 5, 2010
Effects of mild hypothermia on hemodynamics in cardiac arrest survivors and isolated failing human myocardium
Claudius Jacobshagen, Theresa Pelster, Anja Pax, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 8, 2021
Development of a model-based clinical trial simulation platform to optimize the design of clinical trials for Duchenne muscular dystrophy
Karthik Lingineni, Varun Aggarwal, Juan Francisco Morales, et al.
Antimicrobial Agents and Chemotherapy
|
June 6, 2018
Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model
G L Drusano, Jenny Myrick, Michael Maynard, et al.
Antimicrobial Agents and Chemotherapy
|
September 26, 2018
Activity of Moxifloxacin against <i>Mycobacterium tuberculosis</i> in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model
Arnold Louie, Brandon Duncanson, Jenny Myrick, et al.
Pharmaceutics
|
February 25, 2023
Leveraging Physiologically Based Modelling to Provide Insights on the Absorption of Paliperidone Extended-Release Formulation under Fed and Fasting Conditions
Saima Subhani, Viera Lukacova, Chaejin Kim, et al.
Cardiovascular Diabetology
|
December 24, 2025
Glucagon-like peptide-1 receptor agonists and risk for cardiovascular events in older adults treated with levothyroxine: a target trial emulation
Fanxing Du, Naykky M Singh Ospina, Yishan Chen, et al.
Antimicrobial Agents and Chemotherapy
|
September 9, 2020
Building Optimal Three-Drug Combination Chemotherapy Regimens
G L Drusano, Michael N Neely, Sarah Kim, et al.
Page
of 35